Scientists have long been stumped by the neurodegenerative condition, Alzheimer's disease, and have been working to understand it for more than a century. Doctors believe the cause to be a combination ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics and vaccines targeting toxic misfolded proteins in ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A ...

Blood tests for Alzheimer’s disease are becoming more accurate, but researchers stress the need for caution and further study.

Researchers at the Institute of Nano Science and Technology (INST), Mohali, have identified a new pathway involving ...

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 Trial Builds on Recent Evidence of Persistent ...

Tiziana Life Sciences (TLSA) announces that the first patient has been dosed with intranasal foralumab in its Phase 2 randomized, ...

One of the main proteins that contributes to Alzheimer's disease is called phospho-tau (p-tau). When p-tau gets too many ...